Abridge vs Nym Health (2026)
Both turn a clinical encounter into a billable code and they stop in different places. Abridge captures the conversation and produces documentation pointed at the claim, with coding suggestions travelling alongside the note into a platform already deployed across more than two hundred and fifty health systems. Nym removes the coder entirely for encounters above its confidence threshold, routing them straight to billing, and it publishes that threshold, which almost nobody in this category does. That publication is the reason to take it seriously: an autonomous coder that will not say where it stops is asking for trust it has not earned. For most organisations these are sequential rather than alternative purchases, and the question to settle is the straight through rate measured against a coding audit rather than against either vendor's own number.
- The coding suggestion comes from the encounter as it happened rather than from the note afterwards, and it is cross listed into revenue cycle because the documentation is pointed at the claim from the start.
- It is deployed across more than two hundred and fifty health systems with a full trust centre, so the coding capability arrives inside a platform that has already been through enterprise security review.
- For an organisation that wants one vendor from the microphone to the code, the handoff between documentation and coding never happens.
- It codes autonomously and routes encounters straight to billing with no human involved above its confidence threshold, which is a different economic proposition from suggesting codes to a clinician.
- It publishes that threshold, which is the disclosure this whole category avoids, so a buyer knows where the machine stops rather than trusting that it does.
- For high volume standardised encounter types, autonomous coding removes the coder rather than assisting them, and that is where the savings actually are.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Abridge and Nym Health are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Abridge | Nym Health |
|---|---|---|
| Primary category | Ambient Scribes | Autonomous Medical Coding |
| Founded | 2018 | Not recorded |
| Headquarters | Pittsburgh, Pennsylvania | New York, New York, United States |
| Website | abridge.com | nym.health |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Abridge its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and Model Supply Chain Disclosure. Set against Nym Health, Abridge grades higher on several axes, including Model Supply Chain Disclosure, Clinical and Operational Evidence and HIPAA and BAA Posture. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Nym Health its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Set against Abridge, Nym Health grades higher on Model and Technology Transparency, FDA and Regulatory Status and AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Abridge or Nym Health?
On the axes where the AI Health Index separates them, Abridge grades higher on several axes, including Model Supply Chain Disclosure, Clinical and Operational Evidence and HIPAA and BAA Posture, and Nym Health grades higher on Model and Technology Transparency, FDA and Regulatory Status and AI Liability and Recourse. Abridge leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Abridge and Nym Health differ most?
The widest separation the AI Health Index records between Abridge and Nym Health is on Model Supply Chain Disclosure, where Abridge grades A and Nym Health grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Abridge and Nym Health grade the same?
The AI Health Index grades Abridge and Nym Health the same on several axes, including AI Centrality, Autonomy and Oversight Model and AI Safety and PHI Stewardship. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
These are complementary far more often than competitive: a scribe that suggests codes still leaves a coder in the loop, while an autonomous engine removes them for the encounters it is confident about, and a health system may run both. The number that separates them is the straight through rate, the proportion of encounters coded without any human review, measured against a coding quality audit rather than against a vendor claim. Ask Nym for the audit methodology and sample size behind its rate, and ask Abridge what proportion of its suggested codes are accepted unchanged. Neither publishes pricing.